These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19919904)

  • 1. Placebo responses in randomized trials of antiepileptic drugs.
    Guekht AB; Korczyn AD; Bondareva IB; Gusev EI
    Epilepsy Behav; 2010 Jan; 17(1):64-9. PubMed ID: 19919904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis.
    Kemmler G; Hummer M; Widschwendter C; Fleischhacker WW
    Arch Gen Psychiatry; 2005 Dec; 62(12):1305-12. PubMed ID: 16330718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies.
    Leentjens AF; Koester J; Fruh B; Shephard DT; Barone P; Houben JJ
    Clin Ther; 2009 Jan; 31(1):89-98. PubMed ID: 19243709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying baseline characteristics of placebo responders versus nonresponders in randomized double-blind trials of refractory partial-onset seizures.
    Niklson I; Edrich P; Verdru P
    Epileptic Disord; 2006 Mar; 8(1):37-44. PubMed ID: 16567324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of levetiracetam: a review of three pivotal clinical trials.
    Privitera M
    Epilepsia; 2001; 42 Suppl 4():31-5. PubMed ID: 11564123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placebo response and antidepressant clinical trial outcome.
    Khan A; Detke M; Khan SR; Mallinckrodt C
    J Nerv Ment Dis; 2003 Apr; 191(4):211-8. PubMed ID: 12695731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of placebo rates in major depressive disorder trials.
    Stolk P; Ten Berg MJ; Hemels ME; Einarson TR
    Ann Pharmacother; 2003 Dec; 37(12):1891-9. PubMed ID: 14632596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
    Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placebo effects in oral triptan trials: the scientific and ethical rationale for continued use of placebo controls.
    Loder E; Goldstein R; Biondi D
    Cephalalgia; 2005 Feb; 25(2):124-31. PubMed ID: 15658949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features associated with placebo response in refractory focal epilepsy.
    Schmidt D; Beyenburg S; D'Souza J; Stavem K
    Epilepsy Behav; 2013 May; 27(2):393-8. PubMed ID: 23490458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J;
    Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moderators of placebo response to antipsychotic treatment in patients with schizophrenia: a meta-regression.
    Welge JA; Keck PE
    Psychopharmacology (Berl); 2003 Feb; 166(1):1-10. PubMed ID: 12494247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of major antiepileptic drugs on attention, reaction time, and speed of information processing: results from a randomized, double-blind, placebo-controlled withdrawal study of seizure-free epilepsy patients receiving monotherapy.
    Hessen E; Lossius MI; Reinvang I; Gjerstad L
    Epilepsia; 2006 Dec; 47(12):2038-45. PubMed ID: 17201701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta-analysis of randomized, double-blind, placebo-controlled, clinical trials.
    Penagos M; Compalati E; Tarantini F; Baena-Cagnani CE; Passalacqua G; Canonica GW
    Allergy; 2008 Oct; 63(10):1280-91. PubMed ID: 18721246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis: the placebo rate of abdominal pain remission in clinical trials of chronic pancreatitis.
    Capurso G; Cocomello L; Benedetto U; Cammà C; Delle Fave G
    Pancreas; 2012 Oct; 41(7):1125-31. PubMed ID: 22513290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Participant expectancies in double-blind randomized placebo-controlled trials: potential limitations to trial validity.
    Colagiuri B
    Clin Trials; 2010 Jun; 7(3):246-55. PubMed ID: 20421243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: reply to Beyenburg et al., 2009.
    Rheims S; Perucca E; Ryvlin P
    Epilepsia; 2010 May; 51(5):935-6. PubMed ID: 20536532
    [No Abstract]   [Full Text] [Related]  

  • 19. Central nervous system adverse effects of new antiepileptic drugs. A meta-analysis of placebo-controlled studies.
    Zaccara G; Gangemi PF; Cincotta M
    Seizure; 2008 Jul; 17(5):405-21. PubMed ID: 18262442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic effect of clinical trials: understanding placebo response rates in clinical trials--a secondary analysis.
    Walach H; Sadaghiani C; Dehm C; Bierman D
    BMC Med Res Methodol; 2005 Aug; 5():26. PubMed ID: 16109176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.